Partnership model to address misconceptions and optimise first-line therapy for rheumatoid arthritis
Presented as an oral presentation at the National Medicines Symposium 2022
Translating evidence into practice through evidence-based resources for the management of Inflammatory Bowel Disease
Poster presentation for SHPA Medicines Management 2021 conference Objective: To identify knowledge gaps of health professionals around biologic treatment for inflammatory…
Engaging Clinicians and Consumers in the design and implementation of a National Education Program for Inflammatory Arthritis
Poster presentation at ARA Annual Scientific Meeting May 2022
Designing a National Education Program to support quality use of medicines in Inflammatory Bowel Disease
The program aims to achieve better patient health outcomes, support optimal use of biological and small molecule medicines and contribute…
What do Rheumatologists think and do in the management of Inflammatory Arthritis: A Baseline Survey
Presented at ARA Annual Scientific Meeting May 2021
Patterns of use of b/tsDMARDS and other medications for with Rheumatoid Arthritis: a retrospective study using PBS data
Presented at ARA Annual Scientific Meeting May 2021 Aims to describe prescribing patterns for biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs)…
Initiating a National Consortium Approach to support optimal use of bDMARDs
Poster presented at ARA Annual Scientific Meeting May 2021
Supporting safe practices for low-dose methotrexate – NMS 2021
Assessment and evaluation of high cost medicines in Australian public hospitals
Poster presentation at SHPA Medicines Management Conference 2015 aiming to describe the decision-making process for access to High Cost Medicines…
Overseeing Biosimilar Use: Guiding Principles for the governance of biological and biosimilar medicines in Australian hospitals
Poster presentation at SHPA Medicines Management Conference 2015. This poster aims to provide guidance for good governance and decision-making in…